×
MedSchool: Ace Your OSCEsThe Medical Company
 
 
 
 
 
GET - On the App Store
View
Drug Guide
 
 

Palbociclib

 
Bookmark
  •  
    Oral
    Palbociclib
    Ibrance 
  • Mechanism of Action

  • Selectively inhibits cyclin-dependent kinase (CDK) 4 and 6, which act downstream of multiple mitogenic signalling pathways to stimulate cell proliferation.

Clinical Use

  • Indications

  • HER2 negative, ER / PR positive advanced or metastatic breast cancer in men or postmenopausal women (in combination with an aromatase inhibitor).
  • Adverse Effects
  • Neutropaenia (~75% of cases)
  • Nausea / vomiting / diarrhoea
  • Fatigue
  • Alopecia
  • Rash
  • LFT derangement
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now